Published in J Urol on May 01, 1992
Internet-based prescription of sildenafil: a 2104-patient series. J Med Internet Res (2001) 1.15
Transition zone cancers undermine the predictive accuracy of Partin table stage predictions. J Urol (2005) 1.39
[Penetration of methylmethacrylate-monomer in blood circulation following hip joint prosthesis surgery in man]. Chirurg (1974) 1.30
Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol (1991) 1.21
Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy. J Urol (1999) 1.14
A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol (2001) 1.13
Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. Eur J Cancer Care (Engl) (2010) 1.10
Stage migration in clinically localized prostate cancer. Eur Urol (2000) 1.04
Urodynamic evaluation of changes in urinary control after radical retropubic prostatectomy. J Urol (1997) 1.04
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics. Eur Urol (1999) 1.03
Urological findings in patients with neurosurgically treated tethered spinal cord. J Urol (1993) 0.99
[Transrectal ultrasound-guided punch biopsies of the prostate. Indication, technique, results, and complications]. Urologe A (2003) 0.98
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml. Prostate (2001) 0.96
Correlation of symptoms and results of direct bacterial localization in patients with urinary tract infections. J Urol (1984) 0.96
[Influence of the bone-cement mixing time on hypotonic blood circulation reactions in hip-joint replacement surgery]. Chirurg (1975) 0.95
Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival. J Urol (1984) 0.95
CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene (2006) 0.93
Inhaled interleukin-2 therapy in pulmonary metastatic renal cell carcinoma: six years of experience. Cancer J Sci Am (1997) 0.93
The oxygen supply of the dog kidney: measurements of intrarenal pO 2 . Microvasc Res (1972) 0.92
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer. J Urol (2000) 0.92
Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol (1994) 0.92
The expression of angiopoietins and their receptor Tie-2 in human prostate carcinoma. Anticancer Res (2001) 0.91
Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis. Study in a north German population. Eur Urol (1985) 0.91
Molecular heterogeneity of free PSA in sera of patients with benign and malignant prostate tumors. Eur Urol (1999) 0.89
Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer. BJU Int (2003) 0.89
Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer. Anticancer Res (2000) 0.89
Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene. Prostate (2011) 0.88
Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate (2001) 0.88
Improved net sodium transport of the isolated rat kidney. Z Gesamte Exp Med (1971) 0.87
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence. Eur Urol (2001) 0.87
Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patients. Oncol Lett (2010) 0.85
Thromboembolic complication rate after radical retropubic prostatectomy. Impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomas. Eur Urol (1998) 0.85
Subjective and objective prospective, long-term analysis of quality of life during inhaled interleukin-2 immunotherapy. J Clin Oncol (1999) 0.85
Renal scarring after symptomatic and asymptomatic upper urinary tract infection: a prospective study. J Urol (1982) 0.85
Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma. J Urol (1998) 0.84
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome study. Folia Biol (Praha) (2003) 0.84
Autologous blood transfusion in radical prostatectomy: results in 263 patients. Eur Urol (1995) 0.84
Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinoma. Cancer Res (1989) 0.83
Refluxing chimney versus nonrefluxing LeDuc ureteroileal anastomosis for orthotopic ileal neobladder: a comparative analysis for patients with bladder cancer. J Urol (2006) 0.83
[Perioperative and postoperative complications of pelvic lymphadenectomy and radical prostatectomy in 320 consecutive patients]. Urologe A (1995) 0.83
[Carcinoma in situ of the testis: clinical significance, diagnosis and therapy]. Urologe A (1989) 0.83
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy. Eur J Surg Oncol (2008) 0.82
Human prostate cancer blocks the generation of dendritic cells from CD34+ hematopoietic progenitors. Eur Urol (2001) 0.82
Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients. Eur Urol (1983) 0.82
Reversibility of preglomerular active vasoconstriction in the first weeks after complete unilateral ureteral obstruction by inhibition of prostaglandin synthesis. J Urol (1983) 0.82
[Early complications of radical prostatectomy. Pelvic vein compression caused by wound drainage]. Urologe A (1994) 0.82
Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy. Urology (1998) 0.82
[Effect of dopamine on the intrarenal cAMP concentration]. Verh Dtsch Ges Inn Med (1975) 0.82
Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder. Eur Urol (2001) 0.81
Pyelonephritic scarring in 213 patients with upper and lower urinary tract infections: long-term followup. J Urol (1984) 0.81
Numerical chromosomal aberrations in transition-zone carcinomas of the prostate. J Urol (1997) 0.81
Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells. J Cancer Res Clin Oncol (1992) 0.81
Differences in biopsy features between prostate cancers located in the transition and peripheral zone. BJU Int (2003) 0.81
Basal and acetylcholine-stimulated nitric oxide formation mediates relaxation of rabbit cavernous smooth muscle. J Urol (1991) 0.81
Tumor cell deoxyribonucleic acid content and prognosis in human renal cell carcinoma. J Urol (1984) 0.81
The correction of penile curvature with the Essed-Schröder technique: a long-term follow-up assessing functional aspects and quality of life. BJU Int (2000) 0.81
Rectourinary fistula repair using the Latzko technique. J Urol (1999) 0.81
[Surgical results of epididymovasostomy and vaso-vasostomy]. Urologe A (1983) 0.81
[Ambulatory carboplatin monotherapy in advanced seminoma]. Urologe A (1990) 0.80
Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology. J Urol (2000) 0.80
Monoclonal antibodies for characterization of the heterogeneity of normal and malignant transitional cells. J Urol (1987) 0.80
Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment. J Cancer Res Clin Oncol (1994) 0.80
High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens. Eur Urol (2001) 0.80
Pathophysiology of hydronephrotic atrophy: the cause and role of active preglomerular vasoconstriction. Urol Int (1983) 0.80
High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy. Prostate Cancer Prostatic Dis (2013) 0.80
Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder. Oncol Res (1998) 0.80
Cyclooxygenase-2 promotes angiogenesis in pTa/T1 urothelial bladder carcinoma but does not predict recurrence. BJU Int (2003) 0.80
Long-term results of the Stamey bladder neck suspension procedure: a patient questionnaire based outcome analysis. J Urol (1997) 0.80
Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients. Eur Urol (2001) 0.80
Immunohistochemical detection of p53 protein in human prostatic cancer. J Urol (1994) 0.79
[Multilocular, giant angiomyolipoma of the kidney, adrenal gland and para-aortic lymph nodes. Case report of a 9-year-old boy with tuberous sclerosis]. Urologe A (1994) 0.79
Consecutive selective aspiration cytology of renal cortex and renal medulla in kidney transplants. Transplant Proc (1988) 0.79
[Etiology of Goodpasture's syndrome]. Med Klin (1973) 0.79
Innovative treatment for clinically localized adenocarcinoma of the prostate: the future role of molecular imaging. Prostate (1999) 0.79
Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumps. Anticancer Res (2001) 0.79
Influence of low-molecular-weight heparin dosage on red blood cell transfusion, lymphocele rate and drainage duration after open radical prostatectomy. Eur J Surg Oncol (2012) 0.79
[Functional results of various surgical techniques for radical prostatectomy]. Urologe A (2003) 0.79
[Vascular injuries during osteosynthesis in the proximal femoral shaft]. Zentralbl Chir (1974) 0.79
Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2). Anticancer Res (1999) 0.79
Effect of angiotensin II antagonist, alpha-receptor blockage, and denervation on blood flow reduction in experimental, chronic hydronephrosis. Invest Urol (1980) 0.79
Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia. J Urol (1997) 0.79
Dyeing: a simple method for detecting positive or negative surgical margins. Urology (1995) 0.78
Endoscopic bladder neck suspension (Stamey-Pereyra) in female urinary stress incontinence. Long-term follow-up of 66 patients. Eur Urol (1984) 0.78
[Fast-track surgery in radical retropubic prostatectomy. First experiences with a comprehensive program to enhance postoperative convalescence]. Urologe A (2005) 0.78
Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zone. Prostate Cancer Prostatic Dis (2002) 0.78
Do serum C-reactive protein measurements help to discriminate episodes of renal dysfunction in patients after renal transplantation? Clin Chim Acta (2001) 0.78
The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancer. J Urol (1998) 0.78
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]. Urologe A (2001) 0.78
Modified surgical technique to correct congenital and acquired penile curvature. Eur Urol (1991) 0.78
[Ureterorenoscopy (URS) in treatment of ureteral calculi. I. Safety and effectiveness of URS as auxiliary treatment after ESWL]. Urologe A (1999) 0.78
Long-term follow-up of cytostatic intravesical instillation in patients with superficial bladder carcinoma. Is short-term, intensive instillation better than maintenance therapy? Eur Urol (1997) 0.78
[Molecular high throughput research in prostate carcinoma]. Urologe A (2007) 0.78
[Experiences with local collagen injection in male stress incontinence]. Urologe A (1997) 0.77
[Active surveillance for prostate cancer]. Urologe A (2008) 0.77
MR Imaging of Prostate Cancer: Diffusion Weighted Imaging and (3D) Hydrogen 1 (H) MR Spectroscopy in Comparison with Histology. Radiol Res Pract (2010) 0.77
CO2-production by the isolated perfused rat kidney from 14C-labelled substrates. Res Exp Med (Berl) (1973) 0.77
Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer. World J Urol (2001) 0.77